Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jitka, Malcikova"'
Autor:
Terezia Kurucova, Kamila Reblova, Pavlina Janovska, Jakub Pawel Porc, Veronika Navrkalova, Sarka Pavlova, Jitka Malcikova, Karla Plevova, Boris Tichy, Michael Doubek, Vitezslav Bryja, Jana Kotaskova, Sarka Pospisilova
Publikováno v:
Molecular Oncology, Vol 18, Iss 10, Pp 2541-2553 (2024)
Early identification of resistant cancer cells is currently a major challenge, as their expansion leads to refractoriness. To capture the dynamics of these cells, we made a comprehensive analysis of disease progression and treatment response in a chr
Externí odkaz:
https://doaj.org/article/c833416f75ab4151874dbe6f3b782ba0
Autor:
Veronika Mancikova, Michaela Pesova, Sarka Pavlova, Robert Helma, Kristyna Zavacka, Vaclav Hejret, Petr Taus, Jakub Hynst, Karla Plevova, Jitka Malcikova, Sarka Pospisilova
Publikováno v:
Molecular Oncology, Vol 17, Iss 1, Pp 82-97 (2023)
TP53 gene abnormalities represent the most important biomarker in chronic lymphocytic leukemia (CLL). Altered protein modifications could also influence p53 function, even in the wild‐type protein. We assessed the impact of p53 protein phosphorylat
Externí odkaz:
https://doaj.org/article/d23f7fd800de4b44a79aa2866eceb35e
Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
Autor:
Helena Olbertova, Karla Plevova, Sarka Pavlova, Jitka Malcikova, Jana Kotaskova, Kamila Stranska, Michaela Spunarova, Martin Trbusek, Veronika Navrkalova, Barbara Dvorackova, Nikola Tom, Karol Pal, Marie Jarosova, Yvona Brychtova, Anna Panovska, Michael Doubek, Sarka Pospisilova
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Telomeres are protective structures at chromosome ends which shorten gradually with increasing age. In chronic lymphocytic leukemia (CLL), short telomeres have been associated with unfavorable disease outcome, but the link between
Externí odkaz:
https://doaj.org/article/62c7fe3bce37456bb78f5e4434870ef7
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
Externí odkaz:
https://doaj.org/article/cc0c340f1b394e6980ffe0423f1245c0
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/2f2990ffcc574437854eeb9463e6fc2c
Autor:
Veronika Mancikova, Michaela Pesova, Sarka Pavlova, Robert Helma, Kristyna Zavacka, Vaclav Hejret, Petr Taus, Jakub Hynst, Karla Plevova, Jitka Malcikova, Sarka Pospisilova
Publikováno v:
MOLECULAR ONCOLOGY
TP53 gene abnormalities represent the most important biomarker in chronic lymphocytic leukemia (CLL). Altered protein modifications could also influence p53 function, even in the wild-type protein. We assessed the impact of p53 protein phosphorylatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b94f83448458456a9ca3b6618bb055d3
https://doi.org/10.1002/1878-0261.13337
https://doi.org/10.1002/1878-0261.13337
Autor:
Nikola Tom, Ondrej Tom, Jitka Malcikova, Sarka Pavlova, Blanka Kubesova, Tobias Rausch, Miroslav Kolarik, Vladimir Benes, Vojtech Bystry, Sarka Pospisilova
Publikováno v:
BMC Bioinformatics, Vol 19, Iss 1, Pp 1-9 (2018)
Abstract Background High-throughput bioinformatics analyses of next generation sequencing (NGS) data often require challenging pipeline optimization. The key problem is choosing appropriate tools and selecting the best parameters for optimal precisio
Externí odkaz:
https://doaj.org/article/918e3c276a2d4799b3462f8dc2496ba0
Publikováno v:
Frontiers Research Topics ISBN: 9782832519707
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f72fcb657262644fb883b19511106b2d
Autor:
null Veronika Mancikova, null Michaela Pesova, null Sarka Pavlova, null Robert Helma, null Kristyna Zavacka, null Vaclav Hejret, null Petr Taus, null Jakub Hynst, null Karla Plevova, null Jitka Malcikova, null Sarka Pospisilova
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c701c231e672495f249bb95db5df114
https://doi.org/10.1002/1878-0261.13337/v2/response1
https://doi.org/10.1002/1878-0261.13337/v2/response1
Autor:
Lesley-Ann Sutton, Emma Young, Panagiotis Baliakas, Anastasia Hadzidimitriou, Theodoros Moysiadis, Karla Plevova, Davide Rossi, Jana Kminkova, Evangelia Stalika, Lone Bredo Pedersen, Jitka Malcikova, Andreas Agathangelidis, Zadie Davis, Larry Mansouri, Lydia Scarfò, Myriam Boudjoghra, Alba Navarro, Alice F. Muggen, Xiao-Jie Yan, Florence Nguyen-Khac, Marta Larrayoz, Panagiotis Panagiotidis, Nicholas Chiorazzi, Carsten Utoft Niemann, Chrysoula Belessi, Elias Campo, Jonathan C. Strefford, Anton W. Langerak, David Oscier, Gianluca Gaidano, Sarka Pospisilova, Frederic Davi, Paolo Ghia, Kostas Stamatopoulos, Richard Rosenquist
Publikováno v:
Haematologica, Vol 101, Iss 8 (2016)
We report on markedly different frequencies of genetic lesions within subsets of chronic lymphocytic leukemia patients carrying mutated or unmutated stereotyped B-cell receptor immunoglobulins in the largest cohort (n=565) studied for this purpose. B
Externí odkaz:
https://doaj.org/article/565f9a6095ed413e91b042f8d0c0b812